These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 11555585

  • 1. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D.
    Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG.
    Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
    [Abstract] [Full Text] [Related]

  • 3. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C, Krause H, Müller M, Heicappell R, Schrader M, Sachsinger J, Miller K.
    Cancer Res; 2000 Nov 01; 60(21):5941-5. PubMed ID: 11085508
    [Abstract] [Full Text] [Related]

  • 4. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.
    Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372
    [Abstract] [Full Text] [Related]

  • 5. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 6. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.
    Clin Chim Acta; 2004 Dec 20; 350(1-2):181-8. PubMed ID: 15530476
    [Abstract] [Full Text] [Related]

  • 7. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML, Nakayama M, Lee SM, De Marzo AM, Nelson WG.
    Urology; 2004 Feb 20; 63(2):414-8. PubMed ID: 14972513
    [Abstract] [Full Text] [Related]

  • 8. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2002 May 20; 11(5):445-50. PubMed ID: 12010858
    [Abstract] [Full Text] [Related]

  • 9. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV, Guo Z, Epstein JI, Sidransky D.
    J Urol; 2003 Mar 20; 169(3):1138-42. PubMed ID: 12576869
    [Abstract] [Full Text] [Related]

  • 10. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.
    J Cell Biochem; 2004 Feb 15; 91(3):540-52. PubMed ID: 14755684
    [Abstract] [Full Text] [Related]

  • 11. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.
    J Urol; 2008 Feb 15; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [Abstract] [Full Text] [Related]

  • 12. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
    Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM.
    Mol Cell Probes; 2000 Aug 15; 14(4):211-7. PubMed ID: 10970725
    [Abstract] [Full Text] [Related]

  • 13. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
    Vidanes GM, Paton V, Wallen E, Peehl DM, Navone N, Brooks JD.
    Prostate; 2002 Jun 01; 51(4):225-30. PubMed ID: 11987150
    [Abstract] [Full Text] [Related]

  • 14. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
    Rogers CG, Gonzalgo ML, Yan G, Bastian PJ, Chan DY, Nelson WG, Pavlovich CP.
    J Urol; 2006 Nov 01; 176(5):2280-4. PubMed ID: 17070312
    [Abstract] [Full Text] [Related]

  • 15. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 16. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
    Chu DC, Chuang CK, Fu JB, Huang HS, Tseng CP, Sun CF.
    J Urol; 2002 Apr 29; 167(4):1854-8. PubMed ID: 11912447
    [Abstract] [Full Text] [Related]

  • 17. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 29; 7(6):531-6. PubMed ID: 9641498
    [Abstract] [Full Text] [Related]

  • 18. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
    Lee WH, Isaacs WB, Bova GS, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1997 Jun 29; 6(6):443-50. PubMed ID: 9184779
    [Abstract] [Full Text] [Related]

  • 19. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.
    Clin Cancer Res; 2005 Jun 01; 11(11):4037-43. PubMed ID: 15930338
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.